Back
Legend Biotech Quote, Financials, Valuation and Earnings
Sponsored
LEGN
Sponsored
Generate income in just 1 day
Here's the 1-day income strategy for free
Sell
20
LEGN
Legend Biotech
Last Price:
50.33
Seasonality Move:
1.05%
7 Day Trial
ALL ACCESS PASS
$
7
#1 free indicator forecasts the next market drop here
Discover my #1 trading indicator here.Legend Biotech Price Quote
$50.33
+2.04 (+4.22%)
(Updated: September 9, 2024 at 6:55 PM ET)
Legend Biotech Key Stats
Sell
20
Legend Biotech (LEGN)
is a Sell
Day range:
$47.74 - $54.32
52-week range:
$38.60 - $70.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.28
P/B ratio:
7.63%
Volume:
2.8M
Avg. volume:
743.2K
1-year change:
-28.1%
Market cap:
$8.8B
Revenue:
$285.1M
EPS:
$-1.54
How Much Does Legend Biotech Make?
-
How Much Are Legend Biotech's Sales Annually?
LEGN Revenues are $285.1M -
How Much Profit Does Legend Biotech's Make A Year?
LEGN net income is -$518.3M
Is Legend Biotech Growing As A Company?
-
What Is Legend Biotech's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.54% -
What Is Legend Biotech's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Legend Biotech Stock Price Performance
-
Did Legend Biotech Stock Go Up Last Month?
Legend Biotech share price went down by -12.58% last month -
Did LEGN's Share Price Rise Over The Last Year?
LEGN share price fell by -28.1% over the past 1 year
What Is Legend Biotech 52-Week High & Low?
-
What Is Legend Biotech’s 52-Week High Share Price?
Legend Biotech has traded as high as $70.78 over the past 52 weeks -
What Is Legend Biotech’s 52-Week Low Share Price?
Legend Biotech has traded as low as $38.60 over the past 52 weeks
Legend Biotech Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Legend Biotech?
-
How Much Debt Does Legend Biotech Have?
Total long term debt quarterly is $291.6M -
How Much Cash Does Legend Biotech Have?
Cash and short term investments quarterly total is $1.3B -
What Is Legend Biotech’s Book Value Per Share?
Book value per share is 6.33
Is Legend Biotech Cash Flow Positive?
-
What Is LEGN Cash Flow From Operations?
Cash flow from operations (TTM) is -$142.6M -
What Is Legend Biotech’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.7M -
What Is Legend Biotech’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$893.3M
Legend Biotech Return On Invested Capital
-
Is Management Doing A Good Job?
LEGN return on invested capital is -18.44% -
What Is Legend Biotech Return On Assets?
ROA measures how assets are converting to revenues and is -15.5% -
What Is LEGN Return On Equity?
ROE is a measure of profitability and is -22.55%
Legend Biotech Earnings Date & Stock Price
-
What Is Legend Biotech's Stock Price Today?
A single share of LEGN can be purchased today for 48.29 -
What Is Legend Biotech’s Stock Symbol?
Legend Biotech trades on the nasdaq under the ticker symbol: LEGN -
When Is Legend Biotech’s Next Earnings Date?
The next quarterly earnings date for Legend Biotech is scheduled on November 20, 2024 -
When Is LEGN's next ex-dividend date?
Legend Biotech's next ex-dividend date is September 10, 2024 -
How To Buy Legend Biotech Stock?
You can buy Legend Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Legend Biotech Competitors
-
Who Are Legend Biotech's Competitors?
Below is a list of companies who compete with Legend Biotech or are related in some way:
Legend Biotech Dividend Yield
-
What Is LEGN Dividend Yield?
Legend Biotech’s dividend yield currently is 0% -
What Is Legend Biotech’s Payout Ratio?
Legend Biotech’s payout ratio is 0% -
When Did Legend Biotech Last Pay A Dividend?
The latest dividend pay date is September 10, 2024 -
What Is Legend Biotech’s Dividend Per Share?
Legend Biotech pays a dividend of $0.00 per share
Legend Biotech Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 75.98% |
Revenue: | 154.36% | 47.91% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 82.93 |
Upside from Last Price: | 71.74% |